Skip to content

Supportive Care Needs in Melanoma Patients and their Carers

Supportive Care Needs in Australian Melanoma Patients and Carers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12620001277932
Acronym
SCN (Supportive Care Needs)
Enrollment
193
Registered
2020-11-26
Start date
2020-09-03
Completion date
2021-09-28
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This observational study aims to investigate the supportive care needs of melanoma patients across different stages of the disease, as well as their caregivers. Who is it for? Patients- You may be eligible for this study if you are aged 18 years or older, have been diagnosed with melanoma (Stage I-IV), and are either currently undergoing treatment (including chemotherapy, immunotherapy, targeted therapy. radiation therapy or surgery), or have completed treatment within the last two years. Carers- You may be eligible for this study if you are aged 18 years or older, and you are carer to a person diagnosed with melanoma (stage I-IV) who is currently undergoing treatment for their melanoma, or you are a carer to a person diagnosed with melanoma (stage I-IV) who has completed treatment for their melanoma within the last 2 years. Study details All participants (patients and carers) enrolled in this observational study will be asked to complete an online questionnaires asking them about their supportive care needs. It is anticipated that completion of the questionnaires will take about 35 minutes. Following this questionnaire, you will have an opportunity to provide your contact details to be contacted to participate in a semi-structured one-on-one interview with a member of the research team to further discuss their supportive care needs and preferences for future care. It is anticipated that the interview will take 30-60 minutes to complete. It is hoped this research will provide further information regarding areas of concern for melanoma patients and their carers, and that these details will help clinicians to design and provide more useful support systems for melanoma patients in the future.

Interventions

For this observational study, we are interested to examine the supportive care needs that are experienced by melanoma patients and caregivers. We would like to find out whether these needs differ according to stage of disease or place of residence. We would also like to find out correlates of patients' and caregivers' supportive care needs, understand the patients' and carers' preferences for having these needs addressed and ascertain whether all needs are covered in validated questionnaires.

For this observational study, we are interested to examine the supportive care needs that are experienced by melanoma patients and caregivers. We would like to find out whether these needs differ according to stage of disease or place of residence. We would also like to find out correlates of patients' and caregivers' supportive care needs, understand the patients' and carers' preferences for having these needs addressed and ascertain whether all needs are covered in validated questionnaires. 1. Patients and caregivers will be required to complete an online questionnaire that will take approximately 35 minutes of their time. Due to the online nature of data collection, the participants can choose whether to complete all the questions in one session, or over multiple sessions (by saving the form and returning to it later). The questionnaires will be self-report, and hosted on REDCap, online questionnaire administration platform. The patient questionnaire will consist of (1) demographic questions (gender, age, family status, education level, place of residence, income level, time since diagnosis (2) clinical information: melanoma stage, previous melanoma treatment, current melanoma treatment, current disease status, (3) validated questionnaires: Supportive Care Needs Survey - Short Form 34, Supportive Care Needs Survey melanoma module, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Version 3, Melanoma Concerns Questionnaire, Depression, Anxiety and Stress Scale Short Form (4) service utilisation (past and current) questions that have been developed for this study. Caregivers' questionnaire will consist of: (1) demographic information (gender, age, family status, relationship to patient, education, place of residence, income level, time since the person they care for got diagnosed with melanoma (2) clinical information about the patient they care for (stage of melanoma, previous and current treatment, disease status) and (3) validated questionnaires (Supportive Care Needs Survey - Partners and carers, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Version 3, Depression, Anxiety and Stress scales short form (4) service utilisation (past and current) questions that have been developed for this study. 2. The participants will self-select to participate in the interview. All participants will have an opportunity to provide their contact details (email) if they wish to participate in an interview. We will monitor the interview interest to ensure that the variety of disease stages are represented in the interviewed sample. 3. The interview session will be conducted separately from the online questionnaires. It will be organised and conducted by a research assistant, with training in qualitative interview administration and will be supervised by the Principal Investigator.

Sponsors

Melanoma Institute Australia
Lead SponsorCharities/Societies/Foundations

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

PATIENTS: Sufficient English and cognitive ability to understand and respond to Participant Information Statement and study materials Diagnosis of melanoma (stage I-IV) Currently receiving melanoma treatment (e.g. surgery, immunotherapy, targeted therapy, radiation therapy or chemotherapy) OR Melanoma treatment (e.g. surgery, immunotherapy, targeted therapy, radiation therapy or chemotherapy) completed no longer than 2 years ago CARERS: Sufficient English and cognitive ability to understand and respond to Participant Information Statement and study materials Self-identified as a carer to a person diagnosed with melanoma (stage I-IV) is currently undergoing treatment for their melanoma (e.g. surgery, immunotherapy, targeted therapy, radiation therapy or chemotherapy) OR Self-identified as a carer to a person diagnosed with melanoma (stage I-IV) has completed treatment for their melanoma (e.g. surgery, immunotherapy, targeted therapy, radiation therapy or chemotherapy) within the last 2 years Relation could be, but is not limited to significant other (wife, husband, partner etc.), family (mother, father, son, daughter, sibling etc), friend. Relationship is defined by providing informal physical, emotional and / or instrumental support to the person with melanoma.

Exclusion criteria

PATIENTS: Under 18 years of age Diagnosis of cancer other than melanoma in the last 5 years Completed all melanoma treatments (e.g. surgery, immunotherapy, targeted therapy, radiation therapy or chemotherapy) more than 2 years ago CARERS: Under 18 years of age People providing formal / professional support (e.g. community nurses, doctors, allied health team etc) Self-identified as a carer to a person diagnosed with melanoma who has completed their treatment for melanoma (e.g. surgery, immunotherapy, targeted therapy, radiation therapy or chemotherapy) more than 2 years ago

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026